Role of the Immune Environment in Response to Therapy in Breast Cancer

Summary

This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.

Eligibility

Age range

18+ years

Sex

Female

Healthy volunteers

No

Interventions

• Other
  Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.

  Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.

Location